Whole heart engineering represents an incredible journey with as final destination the challenging aim to solve end-stage cardiac failure with a biocompatible and living organ equivalent. Its evolution started in 2008 with rodent organs and is nowadays moving closer to clinical application thanks to scaling-up strategies to human hearts. This review will offer a comprehensive examination on the important stages to be reached for the bioengineering of the whole heart, by describing the approaches of organ decellularization, repopulation, and maturation so far applied and the novel technologies of potential interest. In addition, it will carefully address important demands that still need to be satisfied in order to move to a real clinical translation of the whole bioengineering heart concept.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2AvBdv6
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Kimchi was prepared with different types of salts: purified salt (PS), solar salt aged for 1 year (SS1), aged for 3 years (SS3), a...
-
Abstract Although Nobori ® , with a bioresorbable polymer and biolimus A9 abluminal coating, has unique characteristics, few data exist re...
-
http://ift.tt/2rdV14q
-
Abstract In this study we investigated whether exerting an impulse on a Chronic Total Occlusion (CTO) improves the success rate of CTO cro...
-
Publication date: June 2017 Source: Anesthesiology Clinics, Volume 35, Issue 2 Author(s): Anair Beverly, Alan D. Kaye, Olle Ljungqvist, R...
-
At the King’s Fund’s annual conference on leadership and management last week, NHS England’s chief executive, Simon Stevens, found an innova...
-
Zusammenfassung Nichtmelanozytärer Hautkrebs und seine Frühformen sind aufgrund von steigender Inzidenz und Prävalenz häufige Diagnosen im...
-
2016-10-05T05-46-18Z Source: International Journal of Research in Medical Sciences Noha Seada, Mostafa G. M. Mostafa. Background: Heart...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου